# Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis

> **NCT01391273** · PHASE3 · COMPLETED · sponsor: **Allergan** · enrollment: 173 (actual)

## Conditions studied

- Eyelash Hypotrichosis

## Interventions

- **DRUG:** bimatoprost solution 0.03%
- **DRUG:** bimatoprost vehicle solution

## Key facts

- **NCT ID:** NCT01391273
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07-01
- **Primary completion:** 2012-05-19
- **Final completion:** 2012-05-19
- **Target enrollment:** 173 (ACTUAL)
- **Last updated:** 2019-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01391273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01391273, "Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01391273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*